In his speech, to be presented in the "Cutting Edge Research in Biofabrication and Biomanufacturing" session on Monday, Oct. 24, Guvendiren will give an overview of currently available 3D-printable biomaterials. He will also summarize his recent results from a collaborative project with the New Jersey Center for Biomaterials at Rutgers University on designing novel ink formulations from biodegradable polymers.
“3D printing is emerging as a revolutionary method with the promise to transform medicine as we know it,” Guvendiren says. “One of the bottlenecks is the limited variety of 3D-printable biomaterials with user-defined and tunable properties.”
The opening session keynote speakers include Robert Langer, David H. Koch Institute Professor at MIT, Jennifer Elisseeff, Jules Stein Professor at the Wilmer Eye Institute and the Biomedical Engineering, Translational Tissue, Engineering Center at Johns Hopkins University, and Kam Leong, the Samuel Y Sheng Professor in the Department of Biomedical Engineering & Department of Systems Biology at Columbia University, among others.